Michael J. Fischer

Michael Fischer practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Michael Fischer's NPI, 1013012277, was assigned on September 13, 2006. Michael Fischer graduated from Indiana University School of Medicine in 1996. Michael Fischer holds Illinois license 036111909.

Michael Fischer's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Michael Fischer's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Michael Fischer to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Fischer practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Michael Fischer's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Michael Fischer is licensed in Illinois.

CMS data shows 76 Medicare services from Michael Fischer across 4 procedure codes in 2024, for 52 Medicare patients. Medicare paid $6,094 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Michael Fischer in 2024. The largest group is under 65, with 30 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 71% are also on Medicaid. Their average risk score is 7.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Fischer's median patient age at 64, with 41% women.

In 2024, Michael Fischer wrote 147 Medicare Part D claims for 23 patients. 71% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $9,716 in total drug cost. In 2023, CMS named 205 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Michael Fischer for performance year 2024, reported as part of a group. Michael Fischer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 112 papers to Michael Fischer, published from 2005 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Renal Insufficiency, Chronic, Kidney Failure, Chronic and Renal Dialysis. Michael Fischer has published most often in Clin J Am Soc Nephrol. Michael Fischer's most frequent co-authors are James P. Lash, Ana C. Ricardo, MD, MPH and Claudia Mercedes Lora, MD.

Dmand AI links Michael Fischer to 1 clinical trial. Conditions studied include Opioid-Related Disorders and Narcotic-Related Disorders.

CMS Open Payments shows 1 general payment to Michael Fischer from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Valeant Pharmaceuticals International paid the most, $15.

Michael Fischer graduated from Indiana University School of Medicine in 1996.